Patents
Patents for C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
11/2006
11/16/2006US20060258710 Indolylalkylamino-methylidenecarbamate derivatives useful as gnrh antagonists
11/16/2006US20060258641 Methods and compositions of novel triazine compounds
11/15/2006EP1720839A1 Pyridazinones as antagonists of a4 integrins
11/15/2006EP1633703A4 Isotopically labeled chemically stable reagents and process for the synthesis thereof
11/09/2006US20060252730 Adenosine receptor antagonists and methods of making and using the same
11/08/2006EP1719768A1 Novel benzothiazepine and benzothiepine compounds
11/07/2006US7132541 Microbiocides
11/07/2006US7132432 Antiinflammatory agents; vision defects; autoimmune diseases; hepatitis; cardiovascular disordersl chronic fatigue syndromel chronic ostructive pulmonary disease; congestive heart failure
11/07/2006US7132423 e.g., N-Cycloheptyl-N'(1-ethyl-pyrrolidin-2-ylmethyl)-6-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine-2,4-diamine; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme
11/02/2006WO2006114264A1 Acetylene derivatives
11/02/2006US20060247270 3-Substituted-2(Arylalkyl)-1-Azabicycloalkanes and Methods of Use Thereof
11/02/2006EP1515967B1 2-heteroaryl carboxamides
11/02/2006CA2605267A1 Acetylene derivatives
10/2006
10/31/2006US7129378 Method of preparing amine stereoisomers
10/26/2006WO2006111662A2 4h-1,2,4-triazin-5-one derivatives, their preparation and their use as alpha 7 nicotinic acetylcholine receptors
10/25/2006EP1714965A1 Composition containing solifenacin succinate
10/25/2006EP1713801A1 Process for preparation of 1-(2s,3s)-2-benzhydr yl-n-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amine
10/24/2006US7125870 such as N-hydroxy-2-{3-[4-(2-methyl-quinolin-4-ylmethoxy)-phenyl]-4,5-dihydro-isoxazol-5-yl}-acetamide; kits; for treatment of inflammation
10/24/2006CA2167584C Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity
10/19/2006US20060235054 e.g. 3-substituted 5-(4-fluorophenyl)-4-(4-pyridyl)imidazole-2-thione; immunomodulating and cytokine-release-inhibiting action; antiinflammatory agent
10/19/2006US20060234999 Natural, synthetic or semi-synthetic crude harringtonines purified by chromatography and crystallization in which the solvent is water or lower C1-4 alkanol or an aqueous mixture of organic solvents; treatment of cancer through oral administration
10/19/2006CA2604773A1 Npy antagonists, preparation and use
10/18/2006EP1711473A1 Substituted n-cyclohexylimidazolinones having an mch-modulatory effect
10/18/2006EP1711463A2 Amino-substituted tricyclic derivatives and methods of use
10/17/2006US7122666 Antiinflammatory agents; autoimmune disease; antiarthritic agents
10/17/2006US7122565 Thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors
10/17/2006US7122558 Anticholinergic agents; chronic obstructive pulmonary diseases; incontinence; gastrointestinal disorders; antiulcer agents; cardiovascular disorders
10/17/2006US7122555 Pyrido [2,1-a] isoquinoline derivatives
10/12/2006US20060229334 Biphenyl derivatives
10/11/2006EP1709042A1 Spirocyclic quinuclidinic ether derivatives
10/11/2006CN1279034C Dna-pk抑制剂 Dna-pk inhibitors
10/05/2006WO2006103756A1 Process for production of optically active quinuclidinol
10/05/2006WO2006069097A3 Nicotinic alpha-7 receptor ligands and preparation and uses thereof
10/05/2006US20060223860 e.g. 3-(4-{[6-({(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)-phenyl]ethyl}amino)-hexyl]oxy}butyl)benzenesulfonamide; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist activity; bronchodilator agent; pulmonary disorders: chronic obstructive pulmonary dusease; asthma
10/05/2006US20060223859 Chronic obstructive pulmonary dusease; asthma
10/05/2006US20060223858 Chronic obstructive pulmonary dusease; asthma
10/05/2006US20060223846 Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists
10/04/2006EP1406900B1 Novel compounds, their preparation and use
10/03/2006US7115768 Particularly (adamantylcarbonylamino)acetic acid derivatives
10/03/2006US7115766 Nucleophilic approach for preparing radiolabeled imaging agents and associated compounds
10/03/2006US7115745 Benzyl urea and thiourea derivatives
10/03/2006US7115630 Metabotropic glutamate receptor antagonists
10/03/2006US7115629 Carbamates derived from arylalkylamines
10/03/2006US7115628 obesity, diabetes, male sexual dysfunction, and female sexual dysfunction
09/2006
09/28/2006US20060217415 modulators of nicotinic and/or of the monoamine receptors such as 3-(Dibenzofuran-2-yloxy)-1-azabicyclo[2.2.2]octane, useful for the treatment of nervous system disorders, neurodegenerative diseases and drug abuse and dependence
09/28/2006US20060217414 3-amido-nortropane derivatives; opioid receptor agonist and antigonist; analgesic, anxiolytic, antitussive agent, antidepressant; asthma, alcohol abuse
09/28/2006US20060217406 7-(3-Pyridyl)-1,7-diazaspiro-[4,4]nonane and its salts and proline amides; capable of affecting nicotinic cholinergic receptors, e.g., as modulators of specific nicotinic receptor subtypes; neuroprotective agents
09/27/2006EP1704146A1 Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
09/27/2006EP1703797A2 TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF
09/27/2006EP1458716B1 Bicyclic n-arylamides
09/27/2006EP1286967B1 Cyclohexane derivatives and their use as therapeutic agents
09/26/2006US7112593 N-aryl-substituted cyclic amine derivative and medicine containing the same as active ingredient
09/26/2006US7112587 e.g., N-Cycloheptyl-N'(1-ethyl-pyrrolidin-2-ylmethyl)-6-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine-2,4-diamine; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme
09/20/2006EP1487835B1 Amides of acetic and propionic acids
09/19/2006US7109210 substituted with (hetero)aryl carbonyloxy group and quaternized, e.g., 3(R)-Diphenylacetoxy-1-(3-phenoxy-propyl)-1-azoniabicyclo[2.2.2]octane; bromide; antimuscarinic agents for treating COPD, chronic bronchitis, asthma and rhinitis.
09/14/2006WO2006096807A1 Aza-bridged-bicyclic amino acid derivatives as alpha 4 integrin antagonists
09/14/2006WO2006095671A1 Novel salt of quinuclidine derivative
09/14/2006US20060205953 Isotopically labeled chemically stable reagents and process for the synthesis thereof
09/14/2006US20060205770 Acid addition salts such as (-)-(3R)-quinuclidin-3-yl(1R)-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate (-)-(2S,3S)-tartrate; for treatment of various M3 receptor-mediated diseases such as urinary incontinence, respiratory diseases such as chronic obstructive pulmonary disease
09/14/2006CA2599872A1 Novel salt of quinuclidine derivative
09/13/2006EP1700858A1 Salts of a quinuclidine derivative as muscarinic M3 receptor antagonists
09/13/2006EP1699787A1 Nicotinic acetylcholine receptor ligands
09/13/2006EP1699786A1 Nicotinic acetylcholine receptor ligands
09/13/2006EP1699785A2 3-quinuclidinyl amino-substituted biaryl derivatives
09/13/2006EP1699421A2 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
09/13/2006CN1832948A 1- alkyl-1-azoniabicyclo (2.2.2) octane carbamate derivatives and their use as muscarinic receptor antagonists
09/12/2006US7105663 Derivatives of pyrimido[6,1-a]isoquinolin-4-one
09/12/2006US7105507 Cyclohexane derivatives and their use as therapeutic agents
09/07/2006US20060199839 minimal side effects, improved selectivity, potency, pharmacokinetics, and/or duration of action; 1-isopropyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid {(1S,3R,5R)-8-[3-(4-methanesulfonylpiperazine-1-sulfonyl)propyl]-8-azabicyclo[3.2.1]oct-3-yl}amide; reduced motility of the gastrointestinal tract
09/07/2006US20060199799 Benzimidazolidinone derivatives as muscarinic agents
09/07/2006DE19526233B4 Hydroxylierte Azabicyclooctyl-tetra- und -hexahydrobenz[d,e]isochinolone, deren Herstellung und pharmazeutische Zusammensetzungen, die diese enthalten Hydroxylated Azabicyclooctyl tetra- and -hexahydrobenz [e] isochinolone, their preparation and pharmaceutical compositions containing these
09/05/2006US7101896 Pharmaceutical compositions and methods for use
09/05/2006US7101894 Administering quinoline derivative for therapy of Cytomegalovirus infections in human pathogen
08/2006
08/31/2006WO2006090759A1 Pharmaceutical agent comprising solifenacin
08/31/2006WO2005035507A3 4-aminopyrimidine derivatives for treatment of hyperproliferative disorders
08/31/2006US20060194843 4-(2,6-Dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide; anticancer agents; carcinoma of the colon; antifungal agents; antitumor agents; infections; 4-(2,6-difluoro-benzoylamino)-1H-pyrazole-3-carboxylic acid (1-methyl-piperidin-4-yl)-amide
08/31/2006US20060194803 anti-dementia agent which uses a BEC 1 potassium channel inhibitor as the active ingredient; to improve learning disorder
08/31/2006US20060194790 Bridged bicyclic amine derivatives useful as CCR-3 receptor antagonists
08/30/2006EP1490056B1 N-'4-(2-imino-pyrrolidin-1-yl)phenyl)-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases
08/30/2006CN1826323A 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
08/30/2006CN1824664A Novel quinuclidine derivatives and medicinal compositions containing the same
08/30/2006CN1824663A Preparation method of pentethyl quinamidine optical isomer
08/30/2006CN1272334C Quinuclidine derivs. as muscarinic M3 receptors ligand and their use
08/24/2006WO2006089100A1 Benzoxazole carboxamides for treating cinv and ibs-d
08/24/2006US20060189652 7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide; reacting nitrogen heterocyclic compound with carbonylation agent selected from phosgene, diphosgene, triphosgene, aryl chloroformates, aralkyl chloroformates, alkyl chloroformates, cyclization
08/24/2006US20060189596 Bridged bicyclic amine derivatives useful as CCR-3 receptor antagonists
08/24/2006CA2597962A1 Benzoxazole carboxamides for treating cinv and ibs-d
08/23/2006EP1692085A2 Inhibition of fgfr3 and treatment of multiple myeloma
08/23/2006CN1823036A Novel dibenzo[B,F]oxepine-10-carboxamides and pharmaceutical uses thereof
08/23/2006CN1821241A Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
08/23/2006CN1271054C Urea compounds having muscarinic receptor antagonist activity
08/23/2006CN1270708C Medicinal composition for treating interstitial cystitis
08/22/2006US7094791 Derivatives of 3-hydroxy-pyrrole-2,4-dicarboxylic acid and uses thereof
08/17/2006US20060183904 selective agonists of (MC-4R); obesity, diabetes, male and female sexual dysfunction, insulin resistance, osteoartritis; long duration of action, side effects reduction; stereoisomers
08/17/2006US20060183769 Chemotherapy-induced nausea and vomiting (CINV), diarrhea-predominant Irritable Bowel Syndrome (IBS-D); 5-HT3 inhibitors; N-[3-(2-Methylimidazol-1-yl)propyl]-2-phenylbenzoxazole-4-carboxamide
08/17/2006US20060183742 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses
08/16/2006EP1689722A2 4-aminopyrimidine derivatives for treatment of hyperproliferative disorders
08/16/2006EP1689720A1 Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions
08/16/2006EP1689698A1 Bis-cationic compounds and use thereof
08/16/2006CN1269776C Process for producing carboxylic acid derivative and condensing agent comprising quaternary ammonium salt
1 ... 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ... 58